Sophora flavescens tablets

This product can reduce the level of DHBV-DNA in the serum of ducks infected with duck hepatitis B virus (DHBV); it has a protective effect on toxic liver damage in mice caused by CCl4 and D-galactosamine.

The main ingredient of this product and its chemical name is oxymatrine.

This product is in the form of tablets.

Used for the treatment of chronic hepatitis B and the improvement of serological indicators of liver fibrosis in viral hepatitis [hyaluronic acid (HA) and type III procollagen (PⅢP)].

Chronic hepatitis B: Oral, 0.2g-0.3g (2-3 tablets) each time, three times a day, three months as a course of treatment, or as directed by a doctor. Improvement of serological indicators of liver fibrosis in viral hepatitis [hyaluronic acid (HA) and type III procollagen (PⅢP)]: Oral, 0.3g (3 tablets) each time, three times a day, six months as a course of treatment, or as directed by a doctor.

Patients have good tolerance to this product, and the incidence of adverse reactions is low. Common adverse reactions include nausea, vomiting, bitter taste in the mouth, loss of appetite, diarrhea, upper abdominal discomfort or pain, and fatigue. Occasionally, rash, chest tightness, and fever may occur. Symptoms generally resolve on their own.

It is contraindicated for those who are allergic to this product.

Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: Not yet clear.

Not yet clear.

Protect from light, seal tightly, and store in a cool and dry place.

0.1g (calculated as oxymatrine)

24 months

Shandong Xinhua Pharmaceutical Company Limited

• Founded in:

  1998-11-20

• Address:

  Chemical Industry Zone, Zibo High-tech Industrial Development Zone

• Tax NO.:

  91370300164103727C

• Registered Funds:

  682,407,635 yuan

• Website:

  Log in to view

• Email:

  Log in to view